IPO registrations (S-1, F-1) · Registrants
Bionik Laboratories Corp.
- SEC CIK
- 1508381 · filings on EDGAR ↗
- Former names
- Drywave Technologies, Inc. (2013–2015); Strategic Dental Management Corp. (2011–2013)
- Registration
- Form S-1, first filed 2011-02-08, last 2019-11-12; 8 initial registrations, 26 amendments
- Outcome
- Declared effective 2011-09-06; withdrawal requested 2017-04-18
- Industry (SIC)
- Orthopedic, Prosthetic & Surgical Appliances & Supplies 3842
- Incorporated in
- DE
- Business address
- 80 COOLIDGE HILL ROAD, Watertown, MA 02472
- EIN
- 27-1340346
- EDGAR entity type
- operating
- Insiders and CEO pay
- Bionik Laboratories Corp. on the corporate pages
On this site
- Form D issuer: Bionik Laboratories Corp. EXACT (CIK (EXACT))
- SEC filer: Bionik Laboratories Corp. EXACT (CIK (EXACT))
Filings 44
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2011-02-08 | S-1 | S-1 (registration) | Strategic Dental Management Corp. | 0001014897-11-000011 ↗ |
| 2011-03-29 | S-1/A | S-1/A (amendment) | Strategic Dental Management Corp. | 0001014897-11-000046 ↗ |
| 2011-05-16 | S-1/A | S-1/A (amendment) | Strategic Dental Management Corp. | 0001014897-11-000095 ↗ |
| 2011-08-04 | S-1/A | S-1/A (amendment) | Strategic Dental Management Corp. | 0001014897-11-000135 ↗ |
| 2011-08-24 | S-1/A | S-1/A (amendment) | Strategic Dental Management Corp. | 0001014897-11-000173 ↗ |
| 2011-08-31 | S-1/A | S-1/A (amendment) | Strategic Dental Management Corp. | 0001014897-11-000178 ↗ |
| 2011-09-06 | EFFECT | EFFECT (declared effective) | Strategic Dental Management Corp. | 9999999995-11-002634 ↗ |
| 2015-05-27 | S-1 | S-1 (registration) | Bionik Laboratories Corp. | 0001144204-15-033806 ↗ |
| 2015-05-29 | S-1/A | S-1/A (amendment) | Bionik Laboratories Corp. | 0001144204-15-034532 ↗ |
| 2015-07-15 | S-1/A | S-1/A (amendment) | Bionik Laboratories Corp. | 0001144204-15-042703 ↗ |
| 2015-08-21 | S-1/A | S-1/A (amendment) | Bionik Laboratories Corp. | 0001144204-15-051368 ↗ |
| 2015-08-24 | EFFECT | EFFECT (declared effective) | Bionik Laboratories Corp. | 9999999995-15-002363 ↗ |
| 2015-10-23 | S-1 | S-1 (registration) | Bionik Laboratories Corp. | 0001144204-15-060575 ↗ |
| 2016-02-04 | S-1/A | S-1/A (amendment) | Bionik Laboratories Corp. | 0001144204-16-079043 ↗ |
| 2016-03-23 | S-1/A | S-1/A (amendment) | Bionik Laboratories Corp. | 0001144204-16-089882 ↗ |
| 2016-05-13 | S-1/A | S-1/A (amendment) | Bionik Laboratories Corp. | 0001144204-16-101933 ↗ |
| 2016-07-19 | S-1/A | S-1/A (amendment) | Bionik Laboratories Corp. | 0001144204-16-113601 ↗ |
| 2016-08-10 | S-1 | S-1 (registration) | Bionik Laboratories Corp. | 0001144204-16-117985 ↗ |
| 2016-09-30 | S-1/A | S-1/A (amendment) | Bionik Laboratories Corp. | 0001144204-16-126265 ↗ |
| 2016-11-18 | S-1/A | S-1/A (amendment) | Bionik Laboratories Corp. | 0001144204-16-135378 ↗ |
| 2016-12-20 | EFFECT | EFFECT (declared effective) | Bionik Laboratories Corp. | 9999999995-16-006502 ↗ |
| 2016-12-27 | S-1/A | S-1/A (amendment) | Bionik Laboratories Corp. | 0001144204-16-141424 ↗ |
| 2016-12-28 | EFFECT | EFFECT (declared effective) | Bionik Laboratories Corp. | 9999999995-16-006562 ↗ |
| 2017-02-03 | EFFECT | EFFECT (declared effective) | Bionik Laboratories Corp. | 9999999995-17-000283 ↗ |
| 2017-02-22 | S-1 | S-1 (registration) | Bionik Laboratories Corp. | 0001144204-17-010288 ↗ |
| 2017-02-27 | S-1/A | S-1/A (amendment) | Bionik Laboratories Corp. | 0001144204-17-011352 ↗ |
| 2017-04-18 | RW | RW (withdrawal request) | Bionik Laboratories Corp. | 0001654954-17-003422 ↗ |
| 2017-12-21 | S-1 | S-1 (registration) | Bionik Laboratories Corp. | 0001144204-17-064818 ↗ |
| 2018-01-04 | S-1/A | S-1/A (amendment) | Bionik Laboratories Corp. | 0001144204-18-000779 ↗ |
| 2018-01-08 | EFFECT | EFFECT (declared effective) | Bionik Laboratories Corp. | 9999999995-18-000076 ↗ |
| 2018-10-23 | EFFECT | EFFECT (declared effective) | Bionik Laboratories Corp. | 9999999995-18-002688 ↗ |
| 2018-10-29 | S-1 | S-1 (registration) | Bionik Laboratories Corp. | 0001144204-18-055879 ↗ |
| 2018-11-19 | S-1/A | S-1/A (amendment) | Bionik Laboratories Corp. | 0001144204-18-060818 ↗ |
| 2018-12-31 | S-1/A | S-1/A (amendment) | Bionik Laboratories Corp. | 0001144204-18-066654 ↗ |
| 2019-01-08 | S-1/A | S-1/A (amendment) | Bionik Laboratories Corp. | 0001144204-19-000962 ↗ |
| 2019-01-23 | S-1/A | S-1/A (amendment) | Bionik Laboratories Corp. | 0001144204-19-002465 ↗ |
| 2019-02-14 | S-1/A | S-1/A (amendment) | Bionik Laboratories Corp. | 0001144204-19-007919 ↗ |
| 2019-02-15 | S-1/A | S-1/A (amendment) | Bionik Laboratories Corp. | 0001144204-19-008703 ↗ |
| 2019-02-25 | S-1/A | S-1/A (amendment) | Bionik Laboratories Corp. | 0001144204-19-009867 ↗ |
| 2019-03-18 | RW | RW (withdrawal request) | Bionik Laboratories Corp. | 0001144204-19-014399 ↗ |
| 2019-09-16 | S-1 | S-1 (registration) | Bionik Laboratories Corp. | 0001144204-19-044744 ↗ |
| 2019-10-11 | S-1/A | S-1/A (amendment) | Bionik Laboratories Corp. | 0001144204-19-048136 ↗ |
| 2019-11-12 | S-1/A | S-1/A (amendment) | Bionik Laboratories Corp. | 0001104659-19-062579 ↗ |
| 2019-11-12 | EFFECT | EFFECT (declared effective) | Bionik Laboratories Corp. | 9999999995-19-002556 ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Lundgreen John | Director,TenPercentOwner | 1 | 2013 | ||
| Ray Brian E. | Director,Officer,TenPercentOwner | CEO, CFO | 1 | 2013 | |
| Kibler Austin | Director,Officer | Chief Executive Officer; Senior Vice President | 2 | 2013–2015 | |
| Bloch Peter D. | Director,Officer | Chairman and CEO; Chief Executive Officer | 4 | 2015 | |
| CAIRES THIAGO MORAIS ULHOA | Director,Officer,TenPercentOwner; Officer | Chief Technology Officer; See Remarks | 3 | 2015 | |
| MARKOW LESLIE NADENE | Officer | Chief Financial Officer | 4 | 2015–2019 | |
| PRYWATA MICHAL | Director,Officer; Director,Officer,TenPercentOwner | Chief Operating Officer; Chief Technology Officer | 5 | 2015–2018 | |
| Hariri Robert J | Director | 2 | 2015 | ||
| ARCHAMBAUD OLIVIER RENE PIERRE | TenPercentOwner | 2 | 2015 | ||
| MATHIEU MARC | Director | 2 | 2015 | ||
| Fried Jules Marc | Officer | VP - U.S. Operations | 2 | 2016 | |
| Krebs Hermano Igo | Officer | Chief Science Officer | 1 | 2016 | |
| McCarthy Timothy A. | Officer | Chief Commercialization Office; Chief CommercializationOfficer; See Remarks | 3 | 2016–2018 | |
| Dusseux Eric Michel | Director; Director,Officer | Chief Executive Officer | 7 | 2017–2019 | |
| Gaston-Dreyfus Remi | Director; Director,TenPercentOwner | 16 | 2017–2023 | ||
| MALONE PETER GERALD | Director | 4 | 2018–2021 | ||
| MARTIN JOSEPH R | Director | 4 | 2018–2021 | ||
| AUBERTON-HERVE ANDRE-JACQUES | Director; Director,Officer; DirectorOther | Chairman | 12 | 2018–2023 | |
| Maloberti Renaud Bertrand | Officer | Chief Commercial Officer | 1 | 2018 | |
| Matine Charles | Director | 5 | 2018–2023 | ||
| Thevenon Audrey | Director | 4 | 2018–2021 | ||
| Wass Loren W. | Officer | See Remarks | 2 | 2019–2021 | |
| Russo Richard Paul Jr | Officer | CEO and President; CFO and Interim CEO; Chief Financial Officer | 3 | 2020–2022 | |
| Gonsalves Daniel | Officer | Executive Vice President & CFO | 1 | 2022 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2017-07-12 | Bionik Laboratories Corp. | Other Health Care | $5,644,238 | $1,250,043 | 51 | 1 |
| 2016-05-02 | Bionik Laboratories Corp. | Other Technology | $26,961,000 | $26,961,000 | 78 | 1 |
| 2015-03-12 | Bionik Laboratories Corp. | Other Technology | $15,400,000 | $13,126,600 | 162 | 3 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.